Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2013; 19(35): 5837-5847
Published online Sep 21, 2013. doi: 10.3748/wjg.v19.i35.5837
Published online Sep 21, 2013. doi: 10.3748/wjg.v19.i35.5837
Figure 1 Study design and flowchart.
In the safety phase, 16 patients daily consumed 5 pieces of toast with Aspergillus niger prolyl endoprotease (AN-PEP) for 2 wk while continuing their gluten-free diet (GFD). Two patients deteriorated on Marsh scores and were excluded. After a 2-wk wash-out period during which the patients continued their usual GFD, the remainder of 14 patients were randomized to the efficacy phase to receive 2 wk of toast with either AN-PEP or placebo while continuing their GFD. CDQ: Celiac disease quality.
- Citation: Tack GJ, van de Water JM, Bruins MJ, Kooy-Winkelaar EM, van Bergen J, Bonnet P, Vreugdenhil AC, Korponay-Szabo I, Edens L, von Blomberg BME, Schreurs MW, Mulder CJ, Koning F. Consumption of gluten with gluten-degrading enzyme by celiac patients: A pilot-study. World J Gastroenterol 2013; 19(35): 5837-5847
- URL: https://www.wjgnet.com/1007-9327/full/v19/i35/5837.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i35.5837